Nektar Therapeutics (NKTR)
70.62
-3.71
(-4.99%)
USD |
NASDAQ |
May 15, 16:00
70.72
+0.10
(+0.14%)
After-Hours: 06:21
Nektar Therapeutics Profit Margin (Quarterly) : -413.4% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 37.36% |
| Aquestive Therapeutics, Inc. | -55.77% |
| Boston Scientific Corp. | 25.74% |
| Esperion Therapeutics, Inc. | -31.45% |
| Corcept Therapeutics, Inc. | -18.92% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -106.7% |
| Return on Assets | -43.70% |
| Return on Invested Capital | -50.56% |
| Gross Profit Margin (Quarterly) | 98.61% |
| Operating Margin (Quarterly) | -352.3% |
| Return on Net Operating Assets | -747.4% |